GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » China Health Group Inc (HKSE:08225) » Definitions » Total Liabilities

China Health Group (HKSE:08225) Total Liabilities : HK$40.04 Mil (As of Jun. 2024)


View and export this data going back to 2003. Start your Free Trial

What is China Health Group Total Liabilities?

China Health Group's Total Liabilities for the quarter that ended in Jun. 2024 was HK$40.04 Mil.

China Health Group's quarterly Total Liabilities increased from Sep. 2023 (HK$0.00 Mil) to Dec. 2023 (HK$38.46 Mil) and increased from Dec. 2023 (HK$38.46 Mil) to Jun. 2024 (HK$40.04 Mil).

China Health Group's annual Total Liabilities declined from Dec. 2021 (HK$47.45 Mil) to Dec. 2022 (HK$41.03 Mil) and declined from Dec. 2022 (HK$41.03 Mil) to Dec. 2023 (HK$38.46 Mil).


China Health Group Total Liabilities Historical Data

The historical data trend for China Health Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Group Total Liabilities Chart

China Health Group Annual Data
Trend Dec12 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.37 48.86 47.45 41.03 38.46

China Health Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 46.81 - 38.46 40.04

China Health Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

China Health Group's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=38.464+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=38.46

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=130.541-92.078
=38.46

China Health Group's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=40.037+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=40.04

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=138.579-98.542
=40.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Group Total Liabilities Related Terms

Thank you for viewing the detailed overview of China Health Group's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Group Business Description

Traded in Other Exchanges
N/A
Address
Building 17, Jianwai SOHO, Chaoyang District, Beijing, CHN
China Health Group Inc is an investment holding company engaged in providing medical care facilities in the People's republic of china. The company provides provision of post launch market research, medical and medical market services (PM services), Provision of contracted pharmaceutical development services (PD services), Provision of contracted clinical research services (CR Services), Drugs technologies, and Other medical services. The majority of the revenue for the company comes from the provision of PM services.
Executives
Guo Xia 2101 Beneficial owner
Winsland Agents Limited 2101 Beneficial owner

China Health Group Headlines

No Headlines